Director Business Analysis
CurrentLead team to effectively execute robust insights generation plans for Jynarque, Vadadustat, Sibeprenlimab, Centanafadine, Ulotarant and Nuedexta.•Leveraged market research insights and collaborated with cross-functional teams to course correct softening Jynarque performance through recommended improvements on Field Force execution, tactics, and message delivery•Led the effort to drive deeper learnings among HCP segments and to leverage those insights to shape marketing and field sales force focus, which resulted into converting more HCPs into Jynarque prescribers and loyalists•Embraced the new Otsuka Customer Engagement Model by creating and delivering field execution reports that highlighted issues and opportunities across all Otsuka Sales regions